Guerbet at ECIO 2025
Lipiodol UltraFluid in HCC
ECIO | April 13th to 16th | Rotterdam, NL
JOIN OUR SYMPOSIUM
TACE in HCC Management: A Multifaceted Approach
Tuesday, April 15th (12:30 - 13:15 CET) - Auditorium 2/SY 331
Hospital Practitioner (APHP) / Head of the Department of Medical Imaging at Beaujon University Hospital in Clichy, (Paris, FR) Hospital Practitioner – University Professor, Interventional Radiologist and Head of the Department of Anesthesia, Surgery, and Interventional Radiology (DACI) at Gustave Roussy,
(Villejuif, FR)
Professor of radiography at the University of Frankfurt and Director of the Institute for Diagnostic and Interventional Radiology at the University Hospital Frankfurt/Main,
(Frankfurt, DE)
Add to calendar
JOIN OUR BOOTH #14
This information is intended for Health Care Professional only. It's intended for international audience or is provided during an international event. Lipiodol® Ultra Fluid (Ethyl esters of iodized fatty acids of poppy seed oil) is not registered in all countries. Be aware that Indications, posology, and presentations may differ from country to country. For current and complete prescribing information refer to the local Summary of Product Characteristics (SmPC) and /or contact your local Guerbet organization. For the SmPC of Lipiodol® and IFU of Qitexio®, please scan the QR code
© Guerbet Group 2025
P25003451 – March 2025